Tevimbra
Tevimbra ingredients
| Active ingredient | Strength |
|---|---|
| Tislelizumab | 10 mg/mL |
What Tevimbra is used for
The FDA lists the approved uses on the official label (below). In the EU, tislelizumab is approved as Tevimbra for:
Non-small cell lung cancer (NSCLC) Tevimbra, in combination with platinum-containing chemotherapy as neoadjuvant treatment and then continued as monotherapy as adjuvant treatment, is indicated for the treatment of adult patients with resectable NSCLC at high risk of recurrence (for selection criteria, see section 5.1).Tevimbra in combination with pemetrexed and platinum containing chemotherapy is indicated for the first-line treatment of adult patients with non-squamous NSCLC whose tumours have PD-L1 expression on ≥50% of tumour cells with no EGFR or ALK positive mutations and who have: locally advanced NSCLC and are not candidates for surgical resection or platinum-based chemoradiation, or metastatic NSCLC. Tevimbra in combination with carboplatin and either paclitaxel or nab-paclitaxel is indicated for the first-line treatment of adult patients with squamous NSCLC who have: locally adv…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Tevimbra
- Generic name
- Tislelizumab-jsgr
- Made by
- BeOne Medicines USA, Inc.
- Forms
- Injection, Solution, Concentrate
- Given
- Intravenous
- Drug class
- Programmed Death Receptor-1 Blocking Antibody
- FDA approval
- Biologic licence (BLA) BLA761232
- On the US market since
- 2024
Official information
- MedlinePlus drug information (search for Tislelizumab-jsgr)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Tevimbra?
Tevimbra (Tislelizumab-jsgr) is a cancer medicine made by BeOne Medicines USA, Inc., approved by the US FDA.
What are the ingredients of Tevimbra?
Tevimbra contains Tislelizumab (10 mg/mL).
Is Tevimbra approved in Europe?
The same active substance is approved in the EU as Tevimbra.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA